George Dmytrenko
Neurology · Pensacola, FLNPI 1104833557
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 61 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$140
- Teva Pharmaceuticals USA, Inc.$85
- Biogen$83
- AbbVie$82
- Sunovion Pharmaceuticals Inc.$67
- Genentech USA, Inc.$48
- plus $494 from 19 others
What the payments were for
- Food & beverage$1,000100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $140 |
| Teva Pharmaceuticals USA, Inc. | 6 | $85 |
| Biogen | 6 | $83 |
| AbbVie(2 entities) | 5 | $82 |
| Sunovion Pharmaceuticals Inc. | 5 | $67 |
| Genentech USA, Inc. | 3 | $48 |
| GE HealthCare | 2 | $46 |
| Amgen | 3 | $44 |
| Avanir Pharmaceuticals, Inc. | 2 | $41 |
| Eisai Inc. | 2 | $38 |
| AstraZeneca | 2 | $33 |
| Acadia Pharmaceuticals Inc | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Portola Pharmaceuticals, LLC | 2 | $26 |
| Strongbridge US Inc. | 2 | $26 |
| CSL Behring | 1 | $23 |
| EMD Serono, Inc. | 2 | $22 |
| Tanabe Pharma America, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Akcea Therapeutics, Inc. | 1 | $19 |
| Adamas Pharmaceuticals, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Livanova USA, Inc. | 1 | $12 |
How this compares
$1,000 in reported general payments places this provider in the 40th percentile of 1,434 neurology providers in Florida.
Other neurology in Pensacola
- David BearPensacola$513K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.